Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Ownership
|
Insiders
Bullboard - Stock Discussion Forum
Dermata Therapeutics Inc
DRMA
Healthcare
Biotechnology
Dermata Therapeutics, Inc. is a late-stage medical dermatology company. The Company is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, XYNGARI and DMT410, both incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety...
of dermatological conditions. Its lead product candidate, XYNGARI, is intended to utilize its Spongilla technology for once weekly treatment of a variety of skin diseases, with its initial focus being the treatment of acne vulgaris, which has a United States market size of approximately 30 million patients seeking treatment. The Company’s second product candidate, DMT410, uses its XYNGARI product candidate as a new method for needle-free intradermal delivery of botulinum toxin for the treatment of multiple aesthetic applications and medical skin diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:DRMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 27, 2025 11:01pm
DRMA.....this is so ridiculous !!!!
I saw this early this morning.....the share price pops right after the NR on huge volume... to be honest I thought to myself.....volume is too big and seems the price action isn't very good. Then
...more
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 27, 2025 8:50am
Buy buddy buy because it's taking off this morning.
This stock is signalling a big uptrend for shareholders today
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon
posted Nov 17, 2025 9:00am by
Forge Resources Corp.
-
|
Forge Resources announces the first gold assay results from the Phase 2 diamond drill program at Alotta, intercepting 105 g/t Au over a core length of 1.25 m. Majority of assays results are still pending ...read more
(10)
•••
MikeTester
X
Post by
MikeTester
on Jan 24, 2025 10:13am
Dermata Therapeutics (NASDAQ:DRMA) – Leveraging Spongi
Interesting play in the dermatology space. DMT310 looks promising with that 45% reduction in inflammatory lesions from Phase 2b. Phase 3 STAR-1 trial is currently at 50/550 patients with top-line
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 24, 2024 9:59am
DRMA...don't be a Bagholder....P.O set up
drma_s3.htm (sec.gov)
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 24, 2024 4:54am
DRMA....early a.m runner on no news
$3.40 in PM trading
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 30, 2024 1:44pm
DRMA ...getting the ST pump....I dare ya!!!
drma_424b3.htm (sec.gov)
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2023 3:26pm
DRMA....All the a.m chasers got their pimples popped
N.L.O.D
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2023 1:40pm
DRMA....warrants exercised NR
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules 2023-11-16 10:32 ET - News Release SAN DIEGO, CA
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2023 10:55am
DRMA ....The Pimple exploded during the 1st 15 minute after
the opening bell As Usual ; )
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2023 8:13am
DRMA ....early a.m runner up on NR...on watch ; )
Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols 2023-11-16 05:03 ET - News Release
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 11, 2023 4:06pm
New Press Release - Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
- Dermata raised $5 million gross proceeds from a public offering in March 2023 -- Dermata submitted an End of Phase 2 meeting package to FDA in April 2023 -- FDA agreed that Dermata's chemistry, manufacturing, and control ("CMC") procedures support the initiation of Phase 3 studies of DMT310 for...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 20, 2023 6:01am
New Press Release - Dermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Package
- FDA agrees that Dermata's CMC procedures and controls support the initiation of Phase 3 studies-- Dermata also submitted an end of phase 2 meeting package to the FDA -SAN DIEGO, CA / ACCESSWIRE / April 20, 2023 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"...
read article.
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 18, 2023 2:50pm
RE:DRMA .... How's the "Spear-catching" going?
Let me re-phrase that..... It was done when the $3.05 couldn't hold
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 18, 2023 2:31pm
DRMA .... How's the "Spear-catching" going?
It wqas done when the $3.05 could hold Cheers !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 18, 2023 10:31am
DRMA ....thru 2 supports previously mentioned....
you are now playing "spear-catching".....this ran on no news...therefore ....it's a paper play Good Luck
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silver North Intersects 13.15 m Averaging 818 g/t Silver and 1.39 g/t Gold at the Haldane Property